Markets:

Overview

News

Currencies

International

Treasuries

Tempest Therapeutics, Inc. - Common Stock (NQ:TPST)

2.420 +0.190 (+8.52%)

Streaming Delayed Price Updated: 3:20 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Tempest Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

The market is filled with gapping stocks in Thursday's session. ↗

January 22, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 20, 2025

Via Benzinga

Tempest Therapeutics Stock Plummets Nearly 50% Amid Shareholder Dilution Fears Following CAR-T Acquisition

November 19, 2025

San Francisco, CA – November 19, 2025 – Tempest Therapeutics, Inc. (NASDAQ: TPST) saw its stock price plummet by a staggering 48.92% today, wiping out nearly half of its market value in a single...

Via MarketMinute

TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction ↗

November 19, 2025

The transaction is expected to close in early 2026, provided it receives all required approvals.

Via Stocktwits

Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results ↗

November 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 19, 2025

Via Benzinga

Nasdaq Gains Over 100 Points; Target Trims Earnings Forecast ↗

November 19, 2025

Via Benzinga

Why Tempest Therapeutics (TPST) Stock Is Down 45% Today ↗

November 19, 2025

Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 11, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

June 09, 2025

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

June 09, 2025

Via Benzinga

Get insights into the top gainers and losers of Monday's pre-market session. ↗

June 09, 2025

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 09, 2025

Via Benzinga

Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success ↗

April 10, 2025

Tempest Therapeutics hires MTS Health to explore M&A and partnerships after Roche shows limited interest in its liver cancer program.

Via Benzinga

Tempest Therapeutics Retail Chatter Explodes As Cancer Drug Developer Mulls Possible Merger ↗

April 10, 2025

CEO Stephen Brady emphasized the company's strong data and regulatory momentum, pointing to Phase 2 results for amezalpat in advanced liver cancer and FDA clearance for a pivotal Phase 3 study.

Via Stocktwits

Topics World Trade

Monday's session: gap up and gap down stocks ↗

April 07, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Tuesday's after hours session: top gainers and losers ↗

March 04, 2025

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 30, 2024

Via Benzinga

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket ↗

October 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 10, 2024

Via Benzinga

Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday? ↗

October 10, 2024

Tempest Therapeutics enters a Phase 3 trial for its liver cancer drug amezalpat, in collaboration with Roche. The trial follows positive data from a Phase 2 study showing improved survival in patients...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 10, 2024

Via Benzinga

Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday? ↗

August 15, 2024

Tempest Therapeutics receives FDA feedback on the Phase 3 trial design for amezalpat (TPST-1120) in combination with Tecentriq and Avastin to treat first-line hepatocellular carcinoma. Study to begin...

Via Benzinga

TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024 ↗

August 09, 2024

TPST stock results show that Tempest Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

$55M Bet On Archer Aviation? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

July 05, 2024

Via Benzinga

Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher ↗

June 20, 2024

Via Benzinga

Topics Stocks

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 20, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.